Trump says U.S. to provide GLP-1 drugs for Medicare patients
Tweet
Share
E-mail
FILE PHOTO: A U.S. flag, a syringe and a vial are seen in this illustration taken May 13, 2025. REUTERS/Dado Ruvic/Illustration/File Photo
THE VILLAGES, Florida, May 1 (Reuters) - U.S. President Donald Trump said on Friday the government is moving to make GLP-1 weight-loss and diabetes drugs available to seniors enrolled in Medicare from July 1.
(Reporting By Jarrett Renshaw; editing by Michelle Nichols )
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Russian drone attack injures five in Ukraine's Odesa, officials say
- Larry Ellison cancels plan to sell Oracle stock worth up to $7.5 billion
- Swedes vote in election that could usher far right into government
Create E-mail Alert Related Categories
ReutersRelated Entities
Donald J. TrumpSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
